Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-3-24
pubmed:abstractText
The multifunctional Y-Box protein 1 (YB-1) exerts positive and negative regulatory effects on gene expression by different mechanisms. Since transcription can be controlled by micro RNAs (miRNAs), YB-1 could also cause effects on gene expression by regulation of cellular miRNAs. To test this hypothesis, a previously established and well-characterized cell model derived from drug-sensitive (EPG85-257P/tetR/YB-1) and multidrug-resistant (EPG85-257RDB/tetR/YB-1) gastric carcinoma cells, in which the expression of YB-1 can be inhibited by tetracycline-dependent triggering of the RNA interference (RNAi) pathway, was investigated concerning their miRNA expression profiles in the presence and absence of YB-1. Microarray hybridizations demonstrated that six miRNAs (miR-96*, miR-210, miR-503, miR-623, miR-1275, miR-1290) were up-regulated more than 1.5-fold in drug-sensitive cells following YB-1 inhibition, but no differences in miRNA expression could be detected in multidrug-resistant cells. Independent validation of these findings by quantitative real-time reverse transcriptase polymerase chain reaction did not confirm these effects. Likewise, an in silico analysis of potential regulatory effects of the miRNAs on their target genes did not support the potential miRNA regulatory effects of YB-1. In conclusion, the data provide evidence that YB-1 has no direct influence on global miRNA expression pattern in different variants of gastric carcinoma cells and, therewith, does not control gene expression by regulation of miRNAs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1791-7530
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
629-33
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20332481-Antibiotics, Antineoplastic, pubmed-meshheading:20332481-Blotting, Northern, pubmed-meshheading:20332481-Blotting, Western, pubmed-meshheading:20332481-DNA-Binding Proteins, pubmed-meshheading:20332481-Daunorubicin, pubmed-meshheading:20332481-Drug Resistance, Neoplasm, pubmed-meshheading:20332481-Gene Expression Profiling, pubmed-meshheading:20332481-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20332481-Humans, pubmed-meshheading:20332481-MicroRNAs, pubmed-meshheading:20332481-Nuclear Proteins, pubmed-meshheading:20332481-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:20332481-RNA, Messenger, pubmed-meshheading:20332481-RNA, Small Interfering, pubmed-meshheading:20332481-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20332481-Stomach Neoplasms, pubmed-meshheading:20332481-Survival Rate, pubmed-meshheading:20332481-Treatment Outcome, pubmed-meshheading:20332481-Tumor Cells, Cultured, pubmed-meshheading:20332481-Tumor Markers, Biological, pubmed-meshheading:20332481-Y-Box-Binding Protein 1
pubmed:year
2010
pubmed:articleTitle
Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.
pubmed:affiliation
Charité Campus Mitte, Institute of Pathology, D-10117 Berlin, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't